Home
Syntactx

Syntactx Market Share Analysis for June 2026

namsa is a world authority in medical device and ivd preclinical/clinical research, biological safety testing and regulatory compliance.

Industry: N/A

Domainsyntactx.com

Year Founded2010

Employees51 - 200

Annual Revenue$10M - $15M

Syntactx

Syntactx (including company regionals)

syntactx.com

See more website traffic and engagement information

Syntactx Revenue up to June 2026 is 10M - 15M

revenue generated by Syntactx top domains

Syntactx top domains revenue over 3 years

Revenue for Syntactx top domains

syntactx.com10M - 15M

See more with Sales Intelligence

Total visits to Syntactx's top domains

Understand Syntactx market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Syntactx's top domains

Analyze Syntactx engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Syntactx's top domains

See how Syntactx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Syntactx top competitors by domain

Top similar sites in June 2026, ranked by their affinity

google.comCompany NameGoogleEmployees> 10001HQUnited States, California, Mountain ViewAnnual revenue> $1BTotal visits86.3BComputers Electronics and Technology > Search Engines

Top technologies used by Syntactx

These are the website technologies, by industry, used by Syntactx top domains

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

5

See all

News & Signals from Syntactx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNamsa, Llc acquired Syntactx on Jan 1st '21.This purchase follows NAMSA’s acquisition of New York-based Syntactx, a leading clinical research services CRO, in January 2021.

NewsSyntactx hires Dorothy Abel as Vice President, Regulatory Strategy.Former U.S. FDA Reviewer for Endovascular Devices Joins Global CRO NEW YORK--(BUSINESS WIRE)-- Syntactx, a global, full-service clinical research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the company as Vice President, Regulatory Strategy.

NewsSyntactx hired Marlene Barton as Vice President, Department Head, Regulatory Affairs on Jul 25th '18.Syntactx, a Contract Research Organization that specializes in medical device, pharmaceutical and genetics clinical trials, today announced the appointments of Marlene Barton to the position of Vice President, Department Head, Regulatory Affairs; Chie Iwaishi to the position of Senior Director, Regulatory Affairs; and Darlene Garner to the position of Manager, Regulatory Affairs.